A PYMNTS Company

Reverse Payment Settlements: Presumptively Bad or Usually Acceptable?

BY | June 27, 2012

Kyle Musgrove, Richard Ripley, Jun 27, 2012 In April 2012, the Federal Trade Commission (“FTC”) suffered yet another rebuke of what FTC Chair Jon Leibowitz has characterized as “one of…

Kyle Musgrove, Richard Ripley, Jun 27, 2012

In April 2012, the Federal Trade Commission (“FTC”) suffered yet another rebuke of what FTC Chair Jon Leibowitz has characterized as “one of the Commission’s top competition priorities,” i.e., stopping “reverse payment” settlements in drug patent litigation. The Eleventh Circuit’s decision in the AndroGel case presents an opportunity to review the concept of reverse payment settlements, the agency’

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 44.211.117.197

Please verify email or join us to access premium content!